Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Xeloda with Radiotherapy in Rectal Cancer
NCT01227707Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2005
- Primary completion
- Aug 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Roche. Started Nov 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01227707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227707.